Human papillomavirus type 16 (HPV16) E6/E7 oncogenes immortalize two types of human genital epithelial cells in vitro, endocervical cells and ectocervical or foreskin keratinocytes. Epithelia reconstructed in in vivo nude mouse implants or in vitro organotypic raft cultures from immortalized endocervical cells form higher grade dysplasia than those from keratinocytes. Here, we compared viral E6/E7 mRNA expression in immortalized cell lines of the three cell types using implants, rafts and in situ hybridization assays. Endocervical cells expressed E6/E7 throughout their reconstructed epithelia. In contrast, oncogenes were limited to basal cells for keratinocyte lower grade dysplasias. To study the role of the HPV16 promoter/enhancer in this repression in the upper layers of keratinocyte epithelia, new cell lines were established by immortalization with E6/E7 controlled by the SV40 promoter. The oncogenes were shown to be controlled from the SV40 elements after immortalization. Nevertheless, E6/E7 in the two cell types had the same cell-speci®c expression pattern as that controlled from the homologous HPV16 promoter. In addition, naturally occurring premalignant lesions having integrated HPV16 DNA expressed E6/E7 extensively in the high-grade dysplastic region of undierentiated metaplasia. On the other hand, oncogene expression was restricted to lower layers in the lower grade dysplastic region of more mature dierentiation. Our data suggest that keratinocytes have an inherent HPV16 promoternonspeci®c mechanism of repression. Apparently this mechanism, which can be acquired during maturation, is initially nonfunctional in in vitro and in vivo epithelia derived from metaplastic endocervical cells.
Introduction
Human papillomaviruses (HPVs) comprise a family of DNA tumor viruses having at least 77 members (zur Hausen, 1996) . HPV16 DNA is the most frequent of the speci®c types found in more than 90% of cervical carcinomas and the cell lines derived from them (zur Hausen, 1996; Pater and Pater, 1985) . Viral genes are actively expressed in both (Schwarz et al., 1985; Pater and Pater, 1988) . The major transforming genes for HPV16 in human cells are the early genes, E6 and E7 Barbosa and Schlegel, 1989) . E6 and E7 proteins bind p53 and RB tumor suppressors, respectively (Dyson et al., 1989; Werness et al., 1990) . Experimentally, HPV16 DNA immortalizes foreskin keratinocytes (Pirisi et al., 1987) . More importantly, HPV16 DNA immortalizes epithelial human ectocervical keratinocytes and endocervical cells (HENs) (Woodworth et al., 1988; Tsutsumi et al., 1992) . Both cell types are potential targets of HPV16-mediated oncogenesis.
The cervix is composed of the ectocervix and the endocervix. Often found between the two is the transformation, or transition, zone (Fu and Reagan, 1989; Tsutsmi et al., 1992) . These three regions can be distinguished and dissected anatomically and histologically (Turyk et al., 1989) . Most cervical cancers occur in the metaplastic strati®ed epithelium lining the transformation zone (Burghardt, 1986) . In contrast, few malignancies occur in the ectocervix, which is covered by native strati®ed squamous epithelium. We previously showed experimentally that metaplastic cells originate from endocervical simple columnar epithelium . In monolayer culture, the expression level of E6/E7 genes in both cell types was comparable. Signi®cantly, HEN immortalized by HPV16 genomic DNA (HEN16-2) display a squamous phenotype that is more immature and more atypical than their keratinocyte counterparts in nude mouse implants (Sun et al., , 1993 . Therefore, the high incidence of HPV-mediated malignancy in the transformation zone is possibly due to a special relationship between cervical squamous metaplasia and HPV16 infection (Burghardt 1986; Fu and Reagan, 1989; zur Hausen and de Villiers, 1994) . Viral oncogenes might be dierentially expressed in in vivo conditions in HEN16-2 and the immortalized ectocervical and foreskin keratinocytes. To address this issue, we examined HPV16 E6/E7 mRNA expression in epithelia reconstructed from immortalized cells of three lines. These cells containing integrated HPV16 DNA were previously established from HEN, human ectocervical cells and human foreskin keratinocytes (HFK and HFK16-3) (Sun et al., 1993) .
Results
HPV16 E6/E7 oncogenes are expressed only in basal keratinocytes but in all layers of endocervical epithelial cells in vivo HPV16 cell-speci®c cervical oncogenesis was studied for HEN16-2, HEC16-2 and HFK16-3. These cells were derived from the human endocervix and ectocervix distant from the transformation zone and the male foreskin (Sun et al., , 1993 . We compared viral E6/E7 oncogene expression in epithelial lesions reconstructed by nude mouse implants from the three types of cultured genital cells. In situ hybridization assays with a-35 S-labelled riboprobe spanning regions of the HPV16 E6/E7 open reading frames were used. This probe hybridized with viral RNA only in HPV16-containing cells in situ, as seen in controls (Figure 1 ). The positive controls were CaSki cervical carcinoma-derived cells harbouring integrated HPV16 (Pater and Pater, 1985) and W12 mild dysplasia-derived cells containing episomal HPV16 DNA (Stanley et al., 1989) . They formed epithelial lesions resembling high-grade cervical intraepithelial neoplasia (CIN III) and low-grade CIN I, respectively. The CaSki implant expressed E6/E7 throughout the epithelium at similar levels in all layers, while the E6/ E7 signal in W12 in vivo was limited to the lower two or three cell layers (Figure 1 ). E6/E7 were not detected in the negative control epithelium from HaCaT, a cell line containing no HPV16 (Figure 1 ; Boukamp et al., 1988) . Sense probe of the same sequences did not hybridize in serial sections (data not shown).
The CIN III in vivo epithelium from the endocervixderived HEN16-2 expressed E6/E7 mRNA throughout the layers, similar to that observed in epithelia from CaSki cultures. The signal level was more hetero- (Figures 1 and 2) . In contrast to the HEN16-2 CIN III, the HEC16-2 and HFK16-3 keratinocyte lowgrade dysplasias displayed E6/E7 signal that was limited to the basal cells (Figure 2 ). They were also weaker than those in the HEN16-2 in vivo epithelium.
The transcription machinery is functional in suprabasal keratinocytes not expressing integrated HPV16 E6/E7 oncogenes
We tested the possibility that HPV16 E6/E7 were nonselectively switched o in the keratinocytes together with cellular gene suprabasal cell transcription. Serial sections of the same in vivo epithelia from the three cell lines were hybridized with a riboprobe for cytokeratin (CK) 1. CK1 is an intermediate ®lament expressed in keratinocytes committed to terminal dierentiation (Knapp and Franke, 1989) . A low level of CK1 mRNA was expressed in all layers of CINs III from HEN16-2 ( Figure 3 ) and CaSki positive control (data not shown). The CK1 expression pattern was notably dierent from that of the HEN16-2 implant in the lowgrade dysplasias reconstructed from HEC16-2 and HFK16-3 keratinocytes. CK1 mRNA was expressed in the suprabasal keratinocytes in which the E6/E7 probe detected no signal, while CK1 was not expressed in the basal layers in vivo (Figures 2 and 3) . Thus, the keratinocyte suprabasal cells repressed HPV16 genes while the transcription machinery was highly functional for CK1.
Dierential expression of integrated HPV16 E6/E7 oncogenes is independent of in vivo control
We compared the expression pattern of E6/E7 in endocervical cells and keratinocytes in vitro to evaluate the eects of in vivo factors in implants. In vivo factors are known to modulate HPV gene expression (Woodworth et al., 1990; Braun et al., 1992; . HPV16-immortalized cells were reconstructed into epithelia resembling those in the implants using the in vitro organotypic raft culture system. Rafts are free of in vivo eects due to their use of a de®ned medium (McCance et al., 1988; Rader et al., 1990) . HEN16-2, HEC16-2 and HFK16-3 formed raft dysplasias morphologically ( Figure 4 ; Shindoh et al., 1995; Sarma et al., 1996) comparable with those Sun et al., 1993) . The in vitro system supported a squamous dierentiation program similar to the one in the in vivo conditions (Figures 2 and 4 ; Boukamp et al., 1990) . Furthermore, in situ hybridization assays revealed that the expression pattern of viral E6/E7 in these rafts resembled that in their implant counterparts (Figures 2 and 4 ). E6/E7 were expressed in almost all HEN16-2 raft CIN III-like cells. In contrast, E6/E7 oncogene signal was restricted to the lower layers of the raft low-grade dysplasias from HEC16-2 and HFK16-3. Although E6/E7 were strictly in the basal cells of the keratinocytes in vivo, the oncogenes were also seen in some raft parabasal cells. The results indicated that the keratinocyte-speci®c mechanism down-regulating the expression of integrated HPV16 oncogenes does not require functions supplied in the in vivo condition.
Repression of integrated E6/E7 oncogenes is independent of the HPV16 promoter
We assayed the expression of TGF-b1 to investigate whether the keratinocyte-speci®c down-regulation of E6/E7 was mediated by HPV16 gene control elements.
A heterologous promoter/enhancer and poly(A) addition signal that would alter the expression pattern of viral oncogenes was used. HPV16 E6/E7 were inserted into a plasmid having SV40 regulatory sequences to construct pSV 2 E6/E7. HEN, HEC and HFK were not immortalized by controls having HPV16 E6 or bacterial chloramphenicol acetyl transferase genes (pSV 2 E6 or pSV 2 cat, respectively). Using pSV 2 E6/E7, E6/E7-immortalized cells were obtained; were designated HEN-SVE6/E7, HEC-SVE6/E7 and HFK-SVE6/E7, respectively; and were stable in culture for more than 1 year. A Southern blot assay showed that all three contained only integrated HPV16 E6/E7 DNA and that the integration sites were dierent (data not shown). Their HPV16 counterparts previously showed a similar integrated pattern (Sun et al., 1993) .
Northern blot was used to evaluate the eect of integration on transcriptional regulation of the E6/E7 HPV16 genes. The results showed that the three cell types expressed the E6/E7 oncogenes from the SV40 elements at similar levels in monolayer culture. The same was seen for the counterparts immortalized by HPV16 genomic DNA. However, expression was Implant CK1
Figure 3 Implant CK1 cellular gene mRNA is expressed in all layers from immortalized endocervical cells and in only suprabasal cell layers, which do not express E6/E7, from keratinocytes. Labels and conditions for CK1 instead of E6/E7 mRNA are as described in Figures 1 and 2 Differential HPV 3 16 oncogene expression Q Sun et al higher for SV40. Furthermore, HEN-SVE6/E7 and HEC-SVE6/E7 showed no response to TGF-b1 ( Figure  5 ). Expression of oncogenes was repressed by TGF-b1 in the HPV16-immortalized cells. In HFK-SVE6/E7, E6/E7 expression was slightly repressed by TGF-b1. HPV16 and 18 expression patterns were also previously found to be aected by unique cellular control sequences adjacent to the integrated viral DNAs (Smits et al., 1991; von Knebel Doeberitz et al., 1991) . In addition, we examined whether the difference in response to TGF-b1 was due to a de®ciency in the cytokine's signal transduction pathways in ectocervical and foreskin keratinocytes. However, the expected down-regulation by TGF-b1 of c-myc expression was seen and the levels of response were similar in all six cell lines ( Figure 5 ; Braun et al., 1990; Woodworth et al., 1990) . The data show that the E6/ E7 oncogenes in cells immortalized by HPV16 genomic DNA and pSV2E6/E7 maintained the ®delity of their regulation by HPV16 or SV40 control elements. Northern blot assay was also useful as a control to re-examine whether the E6/E7 probe for in situ hybridization was speci®c to E6/E7. E6/E7 mRNA was the expected size ( Figure 5 ). All three pSV 2 E6/E7-immortalized cell lines formed multilayered lesions in the raft system (Figure 4, H&E) . The rafts from HFK-SVE6/E7 and HEC-SVE6/E7 were morphologically similar to those from their HPV16-immortalized counterparts. All four showed typical squamous dierentiation with few dysplastic changes. In contrast, the multilayered lesion from HEN-SVE6/E7 displayed immature squamous differentiation and some atypical changes, such as disorganized cells and irregularly shaped nuclei (Figure 6; Fu and Reagan, 1989) . Moreover, in situ hybridization assays revealed that E6/E7 expression in each type of cells had a pattern similar to the pattern in their HPV16-immortalized counterpart (Figures 4 and 6) . Expression of the oncogenes was restricted to the lower layers of the HEC-SVE6/E7 and HFK-SVE6/E7 raft lesions. On the other hand, E6/E7 were expressed in the HEN-SVE6/E7 raft lesion almost uniformly throughout the metaplastic lesion. Despite being restricted to lower layers, subtle dierences were seen among the patterns of E6/E7 expression from the HPV16 and SV40 control elements in the human keratinocyte rafts. While E6/E7 oncogene were detected in the basal and parabasal cells of the HEC16-2 and HFK16-3 low-grade dysplasias, expression was mostly limited to the basal cells of the HEC-SVE6/E7 and HFK-SVE6/E7 lesions. In addition, sporadic cells in the upper layers of the HEC-SVE6/ E7 raft expressed E6/E7. These minor dierences between the HPV16-and pSV 2 E6/E7-immortalized keratinocytes may be due to the distinct E6/E7 integration events (data not shown), or dierent characteristics of the SV40 and HPV16 control elements (Figures 4, 5 and 6) . Nevertheless, these data suggested that the keratinocyte-inherent, squamous dierentiation-dependent repression of the integrated HPV16 oncogenes is not speci®c for the homologous promoter. The data also suggested that metaplastic strati®ed squamous epithelium is indiscriminately lax for expression from various gene control elements. The E6/E7 repression mechanism is functional in naturally occurring HPV16-containing CIN We evaluated the clinical relevance of the above observations. Infections having integrated HPV16 DNA generally express no L1 structural gene and contain undetectable levels of viral DNA in in situ hybridization assays (Nuovo et al., 1991; Cooper et al., 1991; Stoler et al., 1992) . Eight naturally occurring CINs III containing HPV16 infections in the metaplastic epithelium of the transformation zone were examined. Neither L1 RNA nor DNA were detectable in any of the CINs III that were in undierentiated metaplastic epithelium (data not shown). All expressed E6/E7, as shown for CINs IIIA and B (Figure 7 ). E6/E7 in CIN IIIA were expressed in all squamous epithelial layers on the left. Expression was limited in a graded transition as the CIN III was extended from this undierentiated region. Viral E6/E7 ®rst were restricted to the lower half, next limited to the bottom two or three cell layers and then limited to basal cells. Finally, oncogene expression ended in the well dierentiated CIN I-like region on the right. Thus, decreasingly severe CIN and increasingly mature squamous dierentiation accompanied the transition pattern of E6/E7 expression in CIN IIIA. The progressive transition in oncogene expression and pathology relative to the distance from the endocervix was also observed in CIN IIIB, although over a shorter distance.
The overall results suggest that repression of E6/E7 is acquired during the development of mature metaplasia ( Figures 2, 4 and 7) . The restriction of E6/E7 expression from the integrated viral oncogenes in the CINs I undierentiated regions was reminiscent of that of HEC16-2 and HKF16-3. These HPV16-immortalized keratinocytes had less severe pathology in their well dierentiated reconstructed epithelia. In contrast, the naturally occurring CINs III regions resembled the reconstructed implant and raft CINs III from HEN16-2 endocervical cells. All had more severe pathology, had unrestricted E6/E7 expression and formed immaturely dierentiated strati®ed squamous epithelia. 
Discussion
Cervical carcinoma is one of the most common neoplasms in the world (Parkin et al., 1993) . Most cervical malignancies are preceded by well de®ned continuously progressive premalignant dysplasia, the CINs (Fu and Reagan, 1989) . Although the transformation zone has been long established as the site most susceptible to oncogenesis, the mechanism remains unclear. This study evolved from our previous studies addressing this issue (Sun et al., , 1993 . HPV16 E7 alone immortalizes human keratinocytes, but ecient immortalization requires the cooperation of E6 (Halbert et al., 1991) . Further, E6 and E7 expression induces integration of exogenous DNA (Kessis et al., 1996) . Therefore, we examined the expression of the major viral transforming genes, E6/ E7, in dysplasia reconstructed in vivo, in implants from the immortalized cells. These cells contained integrated HPV16 DNA and had dierent epithelial origins Sun et al., 1993) . We showed here that the E6/E7 signal was limited within the basal cell layers in the implant low-grade dysplasias formed by the immortalized keratinocytes. This was analogous to that in CINs I-like regions of naturally occurring CINs IIIA and IIIB, which also contained integrated HPV16 DNA (Figure 7 , data not shown). Experimental cysts produced in nude mice by injecting HPV16-immortalized foreskin keratinocytes showed similar pathological features and patterns of viral oncogene expression (Durst et al., 1991) . Interestingly, extensive E6/E7 signal was detected throughout the in vivo lesion from our immortalized endocervical cells. This was similar to the pattern of E6/E7 expression in cysts produced from the immortalized keratinocytes containing the activated ras oncogene (Durst et al., 1991) . Our previous in vivo observations were that HPV16-immortalized endocervical cells reconstructed pathological and oncogenic features of CIN III. These were distinct from the CIN I features of their keratinocyte counterparts (Sun et al., , 1993 Yang et al., 1996) . Thus, the previous data form a foundation for studying the dierential patterns of E6/ E7 expression in the reconstructed dysplasia.
The contrasting expression patterns of E6/E7 in the dysplasia from HPV16-immortalized HEN and keratinocytes may be signi®cant. The endocervix-derived cells may lack a keratinocyte mechanism to repress integrated HPV16. Conversely, keratinocytes could dierentially lack a mechanism of metaplasia to induce E6/E7 expression. We favour the ®rst hypothesis. The nature of the repression mechanism remains elusive. A mechanism for suppressing integrated HPV was proposed to involve speci®c cellular factors and control elements of the HPV promoter/enhancer (zur Hausen, 1986) . Several lines of evidence supported this hypothesis (Rosl et al., 1988 (Rosl et al., , 1991 Smits et al., 1988; Bosch et al., 1990) . Alternatively, repression of integrated HPV16 may result from gene repression in a widespread level in cells committed to dierentiation. However, the mechanism need not aect all promoters. In agreement, the cellular CK1 promoter and a few other promoters continue to function in dierentiationcommitted keratinocytes. An interesting further experiment will be to study whether the two oncogenic viruses have common, promoter-speci®c elements not found in cellular promoters. These could be dierent from CK1 and other cellular elements.
Our viral promoter-nonspeci®c data is consistent with a widespread mechanism of repression during dierentiation. This possibility was addressed in experiments with our newly established cell lines, HEN-SVE6/E7, HEC-SVE6/E7 and HFK-SVE6/E7. These were immortalized by the HPV16 E6/E7 oncogenes controlled from the SV40 promoter. The in vitro expression of E6/E7 in the new genital cell lines had a pattern distinct from that controlled from the HPV16 homologous promoter in several aspects. This was indicated by their higher expression level and lack of response to TGF-b1. Consistently, the HPV16 promoter has low activity in human ®broblasts, while the SV40 promoter is highly active (Smits et al., 1993) . Others have shown that integration adjacent to cellular promoters or mRNA processing signals can modify the expression of HPV16 and 18 in carcinomas or their cell lines (Smits et al., 1991; von Knebel Doeberitz et al., 1991) . In contrast, CINs I and most CINs III occurring naturally contain episomal HPV DNA and a dierent E6/E7 expression pattern (Durst et al., 1991 ; data not shown). Expression patterns from integrated HPV16 E6/E7 DNA in our naturally occurring CINs III re¯ected closely those of our cultured cells. Generally, our data indicated that the ®delity of regulation of the two viral promoters was maintained. Thus, the epithelial cell lines provided ideal tools to address the roles of viral and tissue speci®city of HPV16 expression patterns in metaplastic endocervical cells and differentiation-committed keratinocytes.
The lesion reconstructed from the endocervical HEN-SVE6/E7 expressed E6/E7 throughout the immaturely dierentiated raft epithelium. The patterns of dierentiation and expression from integrated viral DNA were similar to those of CINs III occurring naturally or from HEN16-2 immortalized by genomic HPV16. Thus, immaturely dierentiated metaplastic epithelium may allow promoters to function in all epithelial layers. Interestingly, E6/E7 mRNA from both SV40 and HPV16 control elements was expressed almost exclusively in the basal undierentiated keratinocytes. The SV40 results parelleled previous reports using various systems (Figure 6 ; Lechner and Laimins, 1991; Woodworth et al., 1992; Blanton et al., 1991) . Our results also suggested that the mechanism for repressing integrated HPV16 was inherent in keratinocytes, and was not speci®c for HPV16 control elements. Consistently, CK1 expression was activated in speci®c layers of dierentiation-committed keratinocyte low-grade dysplasias, but was widely expressed in the HEN16-2 CIN III. The repression pattern in naturally occurring CINs indicated that a repressing function can be acquired in the more maturely dierentiated metaplastic regions of CINs I epithelia. Furthermore, the mechanism for repressing expression of HPV16 E6/E7 oncogenes in the upper cell layers did not function in the immaturely dierentiated CIN III in implants or rafts. Neither did it in the transformation zone that is the site of most cervical cancers (Burghardt, 1986) .
A cell-speci®c mechanism for gene repression has oncologic implications. Dierentiating upper layer keratinocytes are increasingly exposed to environmental mutagens. Genes such as CK1 could continue to be expressed. However, genes that are required for carcinogenic growth could be repressed as an integral part of the keratinocyte terminal dierentiation program. Keratinocytes and more maturely differentiated metaplastic epithelium have restricted expression of viral oncogenes and stable homeostasis control. Advantageously, their integrated HPV should be less oncogenic than that of immature metaplastic cells (Fu and Reagan, 1989) . Expression of HPV oncogenes would subvert squamous maturation and drive more dierentiating metaplastic cells into incoordinate replication. This would result in the accumulation of mutations in immature metaplastic cells, which are lax in controlling homeostasis (Schellhas and Heath, 1969; Averette et al., 1970) . Consistently, CIN and cervical malignancy are more common in metaplastic than keratinocyte strati®ed squamous epithelia (Jenson and Lancaster, 1990) .
Materials and methods

Plasmids
The pSV 2 E6/E7 HPV16 E6/E7 expression plasmid used for transformation was controlled from the SV40 promoter/ enhancer and poly(A) addition signal. pSV 2 E6/E7 was constructed by replacing the dHFR gene contained in the HindIII ± BglII fragment from pSV 2 dHFR (Subramani et al., 1981) with the E6/E7 genes of HPV16 in the nt 57 ± 866 HpaII ± NcoI fragment. pBSE7 (kind gift from NS Belaguli) was used for antisense and control sense RNA probes for HPV16 E6/E7 expression assays. It contains the carboxyl terminal E6 sequences and amino terminal E7 sequences contained in the nt 502 ± 720 HpaII ± SspI fragment of HPV16, and was described previously . The pSV 2 E6 plasmid was constructed by replacement of the dHFR gene with the HPV16 sequences containing E6 ORF alone (HpaII ± NsiI fragment, nt 57 ± 566). 4/1EX.1 (kind gift from FX Bosch) was used as probe for the human CK1 gene and was described previously (Knapp and Franke, 1989; Durst et al., 1991) .
Cell culture and transfection
For generating the pSV 2 E6/E7-immortalized cells, primary HEN and HEC were prepared, as described previously . The cells were derived from cervical specimens obtained from hysterectomies required for benign conditions. Primary HFK were derived from neonatal male circumcision foreskins and were initiated in culture, as described previously (Pirisi et al., 1987; Sun et al., 1993) . All primary cultures and derived cell lines Differential HPV 3 16 oncogene expression Q Sun et al were maintained in keratinocyte growth medium (Clonetics). The cells immortalized by the intact genome of HPV16, HEN16-2, HEC16-2 and HFK16-3, were initiated previously (Sun et al., 1993) . HEN, HEC and HFK were passed upon 70% con¯uence and other cells were passed upon 90% con¯uence. CaSki was cultured in Dulbecco's modi®ed Eagle's medium plus 10% fetal calf serum. W12 cells (Stanley et al., 1989) were passed twice after brief culture in keratinocyte growth medium before in vivo analysis. For transfection, primary cells at 70% con¯uence were harvested and transfected with 5 mg DNA with lipofectin (Bethesda Research Labs), following the supplier's instructions.
Histology
Rafts and patient biopsy sample dysplasias were ®xed in 4% paraformaldehyde, embedded in paran, sectioned, and stained with hematoxylin and eosin (H&E) for histology .
Epithelium reconstruction
In vivo implantation was as described previously . Brie¯y, 10 6 to 10 7 trypsinized cells were seeded onto a 1.5 by 1.5 cm silicone sheet (Dow Coring). The silicone sheet with attached cells was implanted into nude mice. The reconstructed epithelium was recovered after 8 ± 10 days.
In vitro epithelial reconstruction was as described previously (McCance et al., 1988; Rader et al., 1990) . Brie¯y, epithelial cells were seeded on a collagen matrix support containing NIH3T3 cells (strain J2). When the cells reached con¯uence, the gel was raised to the air-media interface. The reconstructed epithelium was recovered after 10 days.
In situ hybridization
To prepare RNA probe, the in vitro transcription reaction contained 40 mM Tris-HC1, pH 7.5, 6 mM MgCl 2 , 2 mM spermidine, 10 mM NaCl, 50 mM dithiotreitol (DTT), 0.5 mM CTP, 0.5 mM GTP, 0.5 mM ATP, 75 mCi [a-
35 S]UTP (New England Nuclear) and 25 units T3 RNA polymerase (Bethesda Research Labs). Poly(A) (5 mg) and 1 unit DNase I (Promega) were added to eliminate the DNA template during incubation at 378C for 60 min. Unincorporated [a- 35 S]UTP was removed by ethanol precipitation and the probes were preserved in 0.1 M DTT at 7708C. The size of the 4/1EX.1 transcripts was reduced by heating the probe at 608C for 72 min in 40 mM NaHCO 3 , 60 mM Na 2 CO 3 .
For in situ hybridization, the reconstructed tissues and clinical samples were ®xed in 4% paraformaldehyde in phosphate buer saline, pH 7.4, 2 mM MgCl 2 for 30 min and preserved in 70% ethanol at 48C until routine processing for paran embedding and sectioning. The 7 mm sections were deparanized in xylene and rehydrated in decreasing concentrations of ethanol. After saturation in H 2 O, the sections were treated with 0.2 M HCl for 5 min, next digested in 10 mg/ml proteinase K in H 2 O for 5 min and then treated in 0.1 M triethanolamine-HCl, pH 8.0, 0.25% acetic anhydride twice for 5 min. Equilibration was in 50% formamide, 10 mM Tris-HCl, pH 7.5, 0.6 M NaCl, 1 mM EDTA, 100 mg/ ml heparin, 50 mM DTT, 0.5 mg/ml salmon sperm DNA and 0.5 mg/ml E. coli tRNA at 508C twice for 30 min. The sections were covered with 15 ml hybridization solution that had been denatured at 708C for 10 min. It contained 50% formamide, 10 mM Tris-HCl, pH 7.5, 0.6 M NaCl, 1 mM EDTA, 100 mg/ml heparin, 50 mM DTT, 0.5 mg/ml salmon sperm DNA, 0.5 mg/ml E. coli tRNA, 10% PEG 8000, 16 Denhardt's solution and 40 000 c.p.m./ml RNA probe. Hybridization was at 508C for 38 h.
Washing was twice in sodium saline citrate (SSC) at 508C for 30 min; 20 mg/ml RNase A, 0.5 M NaCl, 0.01 M DTT at 378C for 30 min; twice in 50% formamide, 26SSC, 0.01 M DTT at 508C for 30 min; and twice in 16SSC, 0.02 M DTT, 0.07% sodium pyrophosphate at 508C for 30 min. The sections were dried, autoradiographed by coating with NTB-2 emulsion (Kodak) and exposed for 7 ± 20 days.
Southern and Northern blot analysis
High molecular weight DNA and whole cellular RNA were isolated as described (Sun et al., 1993) . Ten mg DNA were digested with restriction enzymes. DNA and RNA were analysed on 1% agarose gels, as described (Sun et al., 1993) . DNA and RNA were transferred to BioTrace membranes by vacuum and the membranes were hybridized. For Southern blot, 32 P-dCTP-labelled HPV16 DNA probe was prepared with a random priming kit (Bethesda Research Labs). For Northern blots, HPV16 E6/E7 RNA was hybridized with an RNA antisense probe, which was in vitro-transcribed from pBSE7 using [ 32 P]UTP. For hybridization of c-myc and g-actin RNA, 32 P-dCTP-labelled DNA probes were prepared from the 1370 bp SStI fragment of l-LMC41 and the 2.2 kb BamHI fragment of g-actin cDNA with a random priming kit (Bethesda Research Labs). Washing was at the same temperature as the hybridization with 0.16SSC and 0.1% sodium dodecyl sulphate. For repetitive probing, the membranes were washed thrice with boiled 0.1 sodium dodecyl sulphate in 0.16SSC and reprobed.
Abbreviations CIN, cervical intraepithelial neoplasia; CIN I, low-grade CIN; CIN III, high-grade CIN; CK, cytokeratin; DTT, dithiothreitol; H&E, haematoxylin and eosine; HEC, human ectocervical cells; HEN, human endocervical cells; HFK, human foreskin keratinocytes; HPV, human papillomavirus; SSC, sodium saline citrate.
